End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,11,800 KRW | -0.97% | -5.49% | -10.92% |
16/05 | GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03/05 | Green Cross Widens Q1 Loss, Sales Inch Up 2% | MT |
ETFs positioned on GC Biopharma Corp.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.38% | 2 M€ | -14.14% | ||
0.05% | 2 M€ | -.--% | ||
0.01% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +5.87% | - | |
0.00% | 112 M€ | +4.59% | - | |
0.00% | 34 M€ | +9.10% | - | |
0.00% | 306 M€ | +6.27% | - | |
0.00% | 39 M€ | +5.88% | - | |
0.00% | 34 M€ | +4.20% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.92% | 93Cr | |
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- A006280 Stock
- Funds and ETFs GC Biopharma Corp.